Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

67.25
BATS BZX Real-Time Price
As of 2:21pm ET
 -0.55 / -0.81%
Today’s Change
64.18
Today|||52-Week Range
88.16
-20.19%
Year-to-Date
Sanofi and Johnson & Johnson May Battle for the Right to Overpay for Actelion
7:34am / MotleyFool.com - Paid Partner Content
Eli Lilly Hits 52-Week Low on Poor Data on Alzheimer's Drug
Nov 25 / Zacks.com - Paid Partner Content
Lilly: Jardiance Label to Add Cardiovascular Indication
Dec 06 / Zacks.com - Paid Partner Content
Novo Nordisk: shot in the dark
Nov 25 / FT.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Amazon, Dow Chemical, Ford, Eli Lilly and Eni
Dec 06 / Zacks.com - Paid Partner Content
Stock Market News for November 25, 2016
Nov 25 / Zacks.com - Paid Partner Content
Anavex Life Sciences Corp. in 3 Charts
Dec 06 / MotleyFool.com - Paid Partner Content
Will Lilly's Solanezumab Setback Weigh on Other Alzheimer's Stocks?
Nov 25 / Zacks.com - Paid Partner Content
Top Research Reports for Amazon, Ford & Dow Chemical
Dec 05 / Zacks.com - Paid Partner Content
Lilly's Alzheimer Drug Fails Phase III Study, Stock Down
Nov 24 / Zacks.com - Paid Partner Content
Prevention of Alzheimer's is the way forward
Dec 04 / FT.com - Paid Partner Content
Why Eli Lilly, Kinross Gold, and HP Slumped Today
Nov 23 / MotleyFool.com - Paid Partner Content
7 of the Most Shocking Biotech Pipeline Blowups of 2016
Dec 04 / MotleyFool.com - Paid Partner Content
Eli Lilly's Alzheimer's Drug Is a Bust
Nov 23 / MotleyFool.com - Paid Partner Content
Why Eli Lilly Shares Lost 8% in November
Dec 03 / MotleyFool.com - Paid Partner Content
Why Biogen Shareholders Lost $3 Billion Today
Nov 23 / MotleyFool.com - Paid Partner Content
3 Reasons Why Incyte Corporation Stock Could Soar in 2017
Dec 03 / MotleyFool.com - Paid Partner Content
Why PDL BioPharma Inc. Is Down 14.8% Today
Nov 23 / MotleyFool.com - Paid Partner Content
Biotechs Look Dangerous Again As Trump Rally Fades
Dec 02 / Investing Channel - Paid Partner Content
Why Eli Lilly Is Cratering Today
Nov 23 / MotleyFool.com - Paid Partner Content
Quest to cure Alzheimer's disease exhibits symptoms of failure
Nov 30 / FT.com - Paid Partner Content
Instant Analysis: Eli Lilly Drops Pre-holiday Alzheimer's Bomb
Nov 23 / MotleyFool.com - Paid Partner Content
J&J (JNJ) Stands Tall in 2016: Reasons for Outperformance
Nov 30 / Zacks.com - Paid Partner Content
Allergan Acquires Chase Pharma, Expands CNS Portfolio
Nov 23 / Zacks.com - Paid Partner Content
Biotech Stock Mailbag: Looking for an Investable Idea in Alzheimer's Mine Field
Nov 30 / TheStreet.com - Paid Partner Content
Alzheimer's drug failure deals blow to US drugmaker Eli Lilly
Nov 23 / FT.com - Paid Partner Content
Big Pharma healthcare R&D steps out into the open
Nov 29 / FT.com - Paid Partner Content
High stakes: Eli Lilly's hunt for an Alzheimer's drug
Nov 17 / FT.com - Paid Partner Content
Plaques, tangles and the mystery of Alzheimer's disease
Nov 29 / FT.com - Paid Partner Content
Big pharma is failing to do enough for poor countries
Nov 13 / FT.com - Paid Partner Content
3 Top Drug Stocks for Your Retirement Portfolio
Nov 28 / MotleyFool.com - Paid Partner Content
Wall Street rallies led by healthcare and banks
Nov 09 / FT.com - Paid Partner Content
Pharma Stock Roundup: Lilly Alzheimer's Drug Fails, J&J in Acquisition Talks with ALI...
Nov 28 / Zacks.com - Paid Partner Content
US chief executives write open letter to Trump seeking reassurances
Nov 09 / FT.com - Paid Partner Content
Week in Review, November 26
Nov 25 / FT.com - Paid Partner Content